Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROA

Below are the top biotechnology stocks on the NYSE in terms of return on assets. The trailing-twelve-month return on assets at Charles River Laboratories International

is 7.63%. Charles River Laboratories' operating margin for the same period is 16.89%. The trailing-twelve-month return on assets at Emergent BioSolutions

is 7.42%. Emergent BioSolutions' revenue for the same period is $295.23 million. The trailing-twelve-month return on assets at Cambrex

is 6.20%. Cambrex had $33.52 million in total cash for the recent quarter. The trailing-twelve-month return on assets at ShangPharma

is 2.26%. ShangPharma's PEG ratio is 1.20.